KalVista Pharmaceuticals Inc (NASDAQ:KALV) price on Thursday, July 03, rose 1.70% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $11.98.
A look at the stock’s price movement, the close in the last trading session was $11.78, moving within a range at $11.7 and $12.03. The beta value (5-Year monthly) was -0.021. Turning to its 52-week performance, $15.50 and $7.30 were the 52-week high and 52-week low respectively. Overall, KALV moved -10.26% over the past month.
KalVista Pharmaceuticals Inc’s market cap currently stands at around $595.59 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that KALV is a 50% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend KALV as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
KALV’s current price about -4.60% and -3.75% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 46.89, while 7-day volatility ratio is 5.94% and 6.51% in the 30-day chart. Further, KalVista Pharmaceuticals Inc (KALV) has a beta value of 0.03. Analysts have given the company’s stock an average 52-week price target of $20, forecast between a low of $20 and high of $28. Looking at the price targets, the low is -66.94% off current price level while to achieve the yearly target high, price needs to move -133.72%. Nonetheless, investors will most likely welcome a -66.94% jump to $20 which is the analysts’ median price.
If we refocus on KalVista Pharmaceuticals Inc (NASDAQ:KALV), historical trading data shows that trading volumes averaged 1.24 over the past 10 days and 761.43K over the past 3 months. The company’s latest data on shares outstanding shows there are 49.49 million shares.
The 22.58% of KalVista Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 88.43% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 6.25 million on 2025-06-13, giving us a short ratio of 11.1. The data shows that as of 2025-06-13 short interest in KalVista Pharmaceuticals Inc (KALV) stood at 1420.0 of shares outstanding, with shares short rising to 6.11 million registered in 2025-05-15. Current price change has pushed the stock 0.76% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the KALV stock continues to rise going into the next quarter.
